What the Options Market Tells Us About Gilead Sciences
Portfolio Pulse from Benzinga Insights
Deep-pocketed investors show a divided sentiment on Gilead Sciences (NASDAQ:GILD), with options activity suggesting a bullish and bearish split. Significant options trades indicate a target price range of $65.0 to $75.0. Gilead's stock is currently down by -1.33%, with an RSI suggesting it may be oversold. An analyst from UBS maintains a Neutral rating with a target price of $75. The company's next earnings report is due in 7 days.
April 18, 2024 | 5:16 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Options activity on Gilead Sciences shows a split sentiment among investors, with a significant price target range. The stock's current dip and upcoming earnings report could influence short-term price movements.
The divided sentiment among investors, as indicated by the options market, suggests uncertainty about GILD's short-term direction. The upcoming earnings report and the current stock dip could lead to increased volatility. The Neutral rating from UBS, despite the stock being potentially oversold, adds to the cautious outlook.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100